Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
J Immunol. 2011 Sep 15;187(6):3300-13. doi: 10.4049/jimmunol.1101080. Epub 2011 Aug 12.
Viruses like HIV and SIV escape from containment by CD8(+) T lymphocytes through generating mutations that interfere with epitope peptide:MHC class I binding. However, mutations in some viral epitopes are selected for that have no impact on this binding. We explored the mechanism underlying the evolution of such epitopes by studying CD8(+) T lymphocyte recognition of a dominant Nef epitope of SIVmac251 in infected Mamu-A02(+) rhesus monkeys. Clonal analysis of the p199RY-specific CD8(+) T lymphocyte repertoire in these monkeys indicated that identical T cell clones were capable of recognizing wild-type (WT) and mutant epitope sequences. However, we found that the functional avidity of these CD8(+) T lymphocytes for the mutant peptide:Mamu-A02 complex was diminished. Using surface plasmon resonance to measure the binding affinity of the p199RY-specific TCR repertoire for WT and mutant p199RY peptide:Mamu-A02 monomeric complexes, we found that the mutant p199RY peptide:Mamu-A02 complexes had a lower affinity for TCRs purified from CD8(+) T lymphocytes than did the WT p199RY peptide:Mamu-A*02 complexes. These studies demonstrated that differences in TCR affinity for peptide:MHC class I ligands can alter functional p199RY-specific CD8(+) T lymphocyte responses to mutated epitopes, decreasing the capacity of these cells to contain SIVmac251 replication.
病毒(如 HIV 和 SIV)通过产生干扰表位肽-MHC I 结合的突变来逃避 CD8(+) T 淋巴细胞的控制。然而,病毒表位的一些突变被选择,这些突变对这种结合没有影响。我们通过研究感染 Mamu-A02(+)恒河猴的 SIVmac251 中一个主要的 Nef 表位来探索这种表位进化的机制。这些猴子中 p199RY 特异性 CD8(+) T 淋巴细胞受体库的克隆分析表明,相同的 T 细胞克隆能够识别野生型 (WT) 和突变表位序列。然而,我们发现这些 CD8(+) T 淋巴细胞对突变肽:Mamu-A02 复合物的功能亲和力降低了。我们使用表面等离子体共振来测量 p199RY 特异性 TCR 库对 WT 和突变 p199RY 肽:Mamu-A02 单体复合物的结合亲和力,发现突变 p199RY 肽:Mamu-A02 复合物与从 CD8(+) T 淋巴细胞中纯化的 TCR 的结合亲和力低于 WT p199RY 肽:Mamu-A*02 复合物。这些研究表明,TCR 对肽-MHC I 配体的亲和力差异可以改变对突变表位的功能性 p199RY 特异性 CD8(+) T 淋巴细胞反应,降低这些细胞控制 SIVmac251 复制的能力。